Clinical trials
Recruiting Phase 2 Schizophrenia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| China Medical University Hospital | 8 |
| AbbVie | 1 |
| Alto Neuroscience | 1 |
| Amit Lotan | 1 |
| Anders Fink-Jensen, MD, DMSci | 1 |
| Boryung Pharmaceutical Co., Ltd | 1 |
| Brigham and Women's Hospital | 1 |
| Eli Lilly and Company | 1 |
| Kynexis B.V. | 1 |
| MapLight Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 23 |
| Psychotic Disorders | 4 |
| Cognitive Dysfunction | 2 |
| Inflammation | 2 |
| Mental Disorders | 2 |
| Alcoholism | 1 |
| Anxiety Disorders | 1 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Generalized Anxiety Disorder | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.